Top compounds associated with response to RSRC1


Feature Type Standardized
Nominal ANOVA
mRNA MS-275 gCSI pan-cancer AAC 0.093 0.09
mRNA indisulam CTRPv2 pan-cancer AAC 0.054 0.09
mRNA PD318088 CTRPv2 pan-cancer AAC -0.058 0.1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.1
mRNA Erlotinib CCLE pan-cancer AAC 0.075 0.1
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC 0.057 0.1
mRNA YM-155 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA Methotrexate FIMM pan-cancer AAC -0.31 0.1
mRNA A-770041 GDSC1000 pan-cancer AAC 0.084 0.1
Download CSV